Authors:
Marco, F
Bureo, E
Ortega, JJ
Badell, I
Verdaguer, A
Martinez, A
Munoz, A
Madero, L
Olive, T
Cubells, J
Castel, V
Sastre, A
Maldonado, MS
Diaz, MA
Citation: F. Marco et al., High survival rate in infant acute leukemia treated with early high-dose chemotherapy and stem-cell support, J CL ONCOL, 18(18), 2000, pp. 3256-3261
Authors:
Canete, A
Navarro, S
Bermudez, J
Pellin, A
Castel, V
Llombart-Bosch, A
Citation: A. Canete et al., Angiogenesis in neuroblastoma: Relationship to survival and other prognostic factors in a cohort of neuroblastoma patients, J CL ONCOL, 18(1), 2000, pp. 27-34
Authors:
Castel, V
Canete, A
Melero, C
Acha, T
Navajas, A
Garcia-Miguel, P
Contra, T
Molina, J
Galaron, P
Cruz, O
Citation: V. Castel et al., Results of the cooperative protocol (N-III-95) for metastatic relapses andrefractory neuroblastoma, MED PED ONC, 35(6), 2000, pp. 724-726
Authors:
Peris, JE
Latorre, JA
Castel, V
Verdeguer, A
Esteve, S
Torres-Molina, F
Citation: Je. Peris et al., Determination of busulfan in human plasma using high-performance liquid chromatography with pre-column derivatization and fluorescence detection, J CHROMAT B, 730(1), 1999, pp. 33-40
Authors:
Mejia, C
Pellin, A
Navarro, S
Castel, V
Llombart-Bosch, A
Citation: C. Mejia et al., A new mutation of the p53 gene in human neuroblastoma, not correlated withN-myc amplification, INT J SUR P, 7(3), 1999, pp. 149-154
Authors:
Mejia, C
Navarro, S
Colamonici, OR
Pellin, A
Castel, V
Llombart-Bosch, A
Citation: C. Mejia et al., Expression of type I interferon receptor and its relation with other prognostic factors in human neuroblastoma, ONCOL REP, 6(1), 1999, pp. 149-153
Authors:
Castel, V
Garcia-Miguel, P
Canete, A
Melero, C
Navajas, A
Ruiz-Jimenez, JI
Navarro, S
Badal, MD
Citation: V. Castel et al., Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting, EUR J CANC, 35(4), 1999, pp. 606-611